Search Ontology:
ChEBI

atogepant

Term ID
CHEBI:196955
Synonyms
  • (3'S)-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
  • AGN-241689
  • atogepant
  • atogepantum
  • MK-8031
  • Qulipta
Definition
A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine.
References
  • cas:1374248-81-3
  • drugbank:DB16098
  • kegg.drug:D11313
  • pubmed:34407343
  • pubmed:34813050
  • pubmed:34964810
  • pubmed:35085204
  • pubmed:35093013
  • pubmed:35230651
  • pubmed:35319319
  • pubmed:35332801
  • pubmed:35358493
  • pubmed:35469689
  • pubmed:35493707
  • pubmed:35675076
  • pubmed:35705886
  • pubmed:35983926
  • pubmed:36153941
  • pubmed:36226229
  • pubmed:36396451
  • pubmed:36552072
  • pubmed:36602199
  • pubmed:36620892
  • pubmed:36651532
  • pubmed:37038933
  • pubmed:37210713
  • pubmed:37278480
  • pubmed:37424270
  • pubmed:37516124
  • pubmed:37516125
  • pubmed:37564925
  • pubmed:37630989
  • pubmed:37638400
  • pubmed:37650778
  • pubmed:37656319
  • wikipedia.en:Atogepant
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from atogepant
Phenotype where environments contain atogepant
Phenotype modified by environments containing atogepant
Phenotype affecting atogepant
Human Disease Model